Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Novartis Scores EU Approval for Meningitis Vaccine

Pharmaceutical giant Novartis (NYSE: NVS  ) announced in a press release Tuesday that the European Commission has granted approval for the company's vaccine for meningitis B (menB), Bexsero. It is the first approved vaccine for treating broad cases of this type of meningitis.

A European panel earlier backed Bexsero's approval bid in November 2012. The company plans to make Bexsero available as soon as possible in Europe, noting that menB is the leading cause of meningitis death in the continent. According to the release, Novartis has begun negotiating with European nations interested in including Bexsero in national immunization programs.

Andrin Oswald, head of Novartis' Vaccines and Diagnostics Division, is quoted in the company press release as saying, "Our vision is a world without meningitis, and our priority is to work with decision makers across Europe to ensure there is broad and timely access to vaccination."

Peak sales estimates vary, with projections of $700 million annually on the low end increasing to high-end estimates of $1 billion or more within the decade.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2207630, ~/Articles/ArticleHandler.aspx, 9/28/2016 8:34:13 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,339.24 110.94 0.61%
S&P 500 2,171.37 11.44 0.53%
NASD 5,318.55 12.84 0.24%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/28/2016 4:02 PM
NVS $81.22 Up +0.34 +0.42%
Novartis CAPS Rating: ****